Business · 18/03/2024

FDA Drafts Guidance for Pharmaceutical Companies on Developing Alzheimer's Disease Treatments

The US Food and Drug Administration (FDA) has released a draft guidance for the pharmaceutical industry on developing drugs for the treatment of early Alzheimer's disease, with the aim of increasing the availability of effective treatments for patients.